Table 4.
Etiology | ETEA score at baseline | ETEA score after BoNT injections | t-value (p) in student’s t-Test | QUEST score at baseline | QUEST score after BoNT injections | t-value (p) in student’s t-test | CGI-I patient score after BoNT injections |
---|---|---|---|---|---|---|---|
All patients interviewed by phone (n = 38) | 35.84 ± 14.26 36 (12–66) |
25.39 ± 14.40 27 (2–58) |
7.69 (<0.001) |
41.76 ± 18.71 46 (4–84) |
28.39 ± 18.55 29 (1–74) |
8.76 (<0.001) |
2.08 ± 0.97 2 (0–4) |
Essential tremor (n = 21) | 40.76 ± 14.37 38 (17–66) |
30.33 ± 14.92 33 (3–58) |
5.03 (<0.001) |
47.00 ± 18.09 49 (18–84) |
32.24 ± 20.19 31 (4–74) |
6.22 (<0.001) |
2.24 ± 1.04 2 (0–4) |
Holmes tremor (n = 8) | 28.63 ± 12.13 32 (13–42) |
21.00 ± 11.31 21 (9–39) |
4.49 (.003) |
42.63 ± 15.32 47 (15–61) |
30.00 ± 14.09 29 (10–55) |
3.7 (.008) |
2.13 ± 0.99 2 (0–3) |
Other tremors (n = 9) | 30.78 ± 12.32 28 (12–52) |
17.78 ± 11.89 13 (2–33) |
4.92 (.001) |
28.78 ± 18.27 21 (4–54) |
18.00 ± 15.34 11 (1–42) |
7.53 (<0.001) |
1.67 ± 0.71 2 (1–3) |
Abbreviations: BoNT, botulinum neurotoxin; CGI-I, Clinical Global Impression-Improvement; ETEA, Essential Tremor Embarrassment Assessment; QUEST, Quality of Life in Essential Tremor.
All descriptive data are quoted as the mean ± standard deviation and the median (range).